Updated:
Forentis Partners
Forentis Partners is a special purpose venture fund. They focus on the pharmaceutical and diagnostic industries. Forentis Partners made a single investment...
Overview
Forentis Partners is a special purpose venture fund. They focus on the pharmaceutical and diagnostic industries. Forentis Partners made a single investment in Blueprint Bio alongside their Series A round on June 20, 2016.
General information
Firm type
Private Equity
Year founded
2016
Location
Region
North America
Country
United States
City
Murrieta
Corporate office
Murrieta, CA, United States
Frequently asked questions
Who runs Forentis Partners?
Named principals and investment decision-makers at Forentis Partners have not been publicly identified. The firm maintains a low public profile with no LinkedIn presence or biographical information available through its website or regulatory filings. This absence of disclosed leadership is noted but not unusual for smaller private equity firms that manage capital without external fundraising from institutional limited partners.
What is Forentis Partners' track record?
No independently verifiable track record data exists for Forentis Partners in the public domain. The firm has not publicly announced fund performance, portfolio exits, or specific investment returns. As a private entity without public reporting obligations, performance data remains confidential unless voluntarily disclosed to prospective investors or partners.
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: